Seer database cancer

    • [DOCX File]Investigator: - National Cancer Institute

      https://info.5y1.org/seer-database-cancer_1_6924f9.html

      You will not attempt to link nor permit others to link the SEER-Medicare data with individually identified records in another database without the written consent from the applicable SEER registries. No one having access to the data will attempt to learn the identity of any persons with cancer in these data and/or their physicians or treating ...


    • Massachusetts Cancer Registry

      SEER*Rx Interactive Antineoplastic Drug Database -- This electronic resource for cancer drug categorization replaces SEER Book 8 (below) for diagnoses made starting in 2005. SEER*Rx can be downloaded after a password has been requested and issued through email.


    • [DOC File]Identification and monitoring of risk factors of cancer ...

      https://info.5y1.org/seer-database-cancer_1_fe3386.html

      Identification of Cancer Risk Factors using a Higher Order Data Representation. Nikita Lytkin, Ilya Muchnik, William M. Pottenger. Over the past few years, we have performed explorative analyses of the Surveillance Epidemiology and End Results (SEER) database. SEER was created by the National Cancer Institute, and is the largest national data ...



    • [DOC File]SEER*Abs System Administration Reference

      https://info.5y1.org/seer-database-cancer_1_8c26d2.html

      Section 1: Using SEER*Abs in a Cancer Registry. SEER*Abs was designed using an extensible architecture so that it can be used by any cancer registry. The screen layouts, search tools, extract files, integrated edits, and synchronization module can be configured to meet the needs of the registry.


    • [DOC File]NAACCR

      https://info.5y1.org/seer-database-cancer_1_221715.html

      Applies to all Cancer Sites: Date treatment started and ended (if available) Facility administering chemo (Full name of facility typed out) Physician ordering chemo (First and last name) Names of drugs given or Protocol: Make sure to check all drugs with the SEER RX Database to make sure they are chemotherapy and not immunotherapy.


    • [DOCX File]Dear Investigator - National Cancer Institute

      https://info.5y1.org/seer-database-cancer_1_74c9d9.html

      description of study subjects and cancer sites/phases to be included in the analysis. ... Variables that require permission of the NCI and the Principal Investigator of each of the SEER Registries. These variables include census tract of the patient, zip code of the patient, physician or hospital, and unencrypted hospital provider numbers. ...


    • REGINFO.GOV

      SEER data are of high quality and are used to analyze long term trends in cancer incidence, patient survival, and for many other research purposes. While the SEER data are appropriate for analyses of major cancers in large population subgroups, they are not always adequate for analysis of U.S. regions, minority populations and rare cancer analyses.


    • [DOC File]Validation of the 8th edition AJCC ... - Journal of Cancer

      https://info.5y1.org/seer-database-cancer_1_62d459.html

      Female BC patients diagnosed between 2010 and 2014 were retrieved from the SEER database established by the National Cancer Institute of the United States, which collected data on demographics, clinical characteristics, the first course of treatments, and follow up for vital status (6).


    • [DOC File]OncoTraX: Cancer Registry

      https://info.5y1.org/seer-database-cancer_1_a25314.html

      OncoTraX: Cancer Registry is an integrated collection of computer programs and routines, which work together in assisting the Cancer Registrars to create and maintain a cancer patient database. The software creates case listings and registry reports for Cancer Boards (Cancer Conferences), special studies, and the Annual Report recommended by ...


    • [DOC File]Journal of Cancer

      https://info.5y1.org/seer-database-cancer_1_aee81a.html

      Surveillance, Epidemiology, and End Results (SEER) Program (www.seer. cancer.gov) SEER*Stat Database: Incidence—SEER 18 Regs Custom Data (with additional treatment fields), Nov 2016 Sub (2004-2015 varying)— Linked to County Attributes—Total U.S., 1969-2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released ...


    • [DOC File]SEER*Abs Users Manual

      https://info.5y1.org/seer-database-cancer_1_6a16e4.html

      SEER*Abs keeps the last 10 extract files for each data type in its database and allow them to be re-created in case they were not been successfully transmitted to the registry. To recover an extract: Go to the Synchronization page (press F4; click the Synchronization toolbar icon; or select Show -> Synchronization).


    • Massachusetts Cancer Registry

      A patient with follicular and/or papillary thyroid cancer is given a synthetic thyroid hormone (in the SEER*Rx Database). Code as Hormone Therapy. Adrenocorticotrophic hormones (usually ancillary) have sometimes been reported as Hormone Therapy for leukemias, lymphomas, myelomas, and breast and prostate cancers; follow the SEER*Rx Database and ...


    • [DOC File]Proceedings Template - WORD

      https://info.5y1.org/seer-database-cancer_1_3983e9.html

      These approaches will be applied to various datasets and particularly to medical ones such as the National Cancer Institute SEER Database of over 40,000 breast cancer cases which has already been mined for practical survival curves.


    • [DOC File]www.medsci.org

      https://info.5y1.org/seer-database-cancer_1_655c60.html

      Our goals were to analyze the prevalence proportions and prognosis of synchronous distant metastases in patients with TSCC using the Surveillance, Epidemiology, and End Results (SEER) database. Materials and Methods. Cohort population. We obtained data from the current SEER database, which consists of 18 population-based cancer registries.


Nearby & related entries: